CPT code 79300 denotes interstitial brachytherapy implantation in which colloidal radioactive material in wires, tubes, or seeds is placed directly over a tumor to provide focused radiation therapy. This procedure is clinically significant for localized cancer management and is performed in settings equipped for radiation delivery, typically hospital operating rooms or radiation oncology suites. Nationally, the code is relevant to payers and providers involved in oncology care coordination, radiation therapy billing, and procedural reimbursement policy.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of the code, the typical sites of service, common billing modifiers associated with the service line (listed separately), and the payer landscape relevant to claims processing. The publication summarizes coding intent, common clinical scenarios for interstitial brachytherapy, and what to expect in payer coverage patterns and documentation requirements.

The report is aimed at billing managers, clinical coders, radiation oncology clinicians, and policy analysts seeking concise guidance on clinical meaning and billing context for CPT code 79300. Data not available in the input includes specific associated taxonomies, ICD-10 diagnoses, related codes, and service-line financial benchmarks.